D C H Molecular Dgnstcs Inc Mountain View, CA - 94043

D C H Molecular Dgnstcs Inc is categorized under Medical Labs in Mountain View, CA and active since 2012.

D C H Molecular Dgnstcs Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6215110 by the NAICS.

If you are seeking more information, feel free to contact Xiangmin Cui at the company’s single location by writing to 1400 Terra Bella Avenue # A, Mountain View, California CA 94043 or by phoning (650) 386-1917. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: D C H Molecular Dgnstcs Inc
Contact Person: Xiangmin Cui
Address: 1400 Terra Bella Avenue # A, Mountain View, California 94043
Phone Number: (650) 386-1917
Website Address: genemdx.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 6215110
Share This Business:

D C H Molecular Dgnstcs Inc was started in 2012 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Xiangmin Cui for inquiries that concern D C H Molecular Dgnstcs Inc by calling the company number (650) 386-1917, as your correspondence is most welcome. Additionally, the physical location of the single location of D C H Molecular Dgnstcs Inc can be found at the coordinates 37.40901,-122.08351 as well as the street address 1400 Terra Bella Avenue # A in Mountain View, California 94043.

For its online presence, you may visit D C H Molecular Dgnstcs Inc’s website at genemdx.com and engage with its social media outlets through on Twitter and on Facebook.